Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Chemotherapy (Florence, Italy)|November 4, 2017
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapyAli Hakan Kaya, Emre Tekgündüz, Kadir Ilkkiliç, et al.Medicine|November 3, 2021
Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center studyAlparslan Merdin, Mehmet Sinan Dal, Merih Kizil Çakar, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 12, 2019
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factorAlparslan Merdin, Merih Kızıl Çakar, Mehmet Sinan Dal, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 4, 2020
The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donorsTuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 4, 2019
The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphomaMerih K Çakar, Emre Tekgündüz, Mehmet S Dal, et al.Medicine|April 4, 2020
Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutationsAlparslan Merdin, Mehmet Sinan Dal, Merih Kizil Çakar, et al.Turkish Journal of Medical Sciences|November 25, 2020
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experienceHikmettullah Batgi, Semih Başcı, Mehmet Sinan Dal, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Pralatrexate experience in PTCL: A multicenter retrospective study from TurkeyMehmet Sinan Dal, Alparslan Merdin, Mehmet Ali Erkurt, et al.Pageof 6